Earnings Call · Q3 FY2022·2022-11-02

Q3 22EPS -3.81%·Rev n/aQ2 22EPS -13.82%·Rev n/aQ1 22EPS -21.51%·Rev n/aQ4 21EPS -18.18%·Rev n/a⚠ consensus missing

Seres Therapeutics, Inc. MCRB

Carlo Tanzi — Head of Investor Relations

Eric Shaff — Chief Executive Officer

Lisa von Moltke — Chief Medical Officer

Matthew Henn — Chief Scientific Officer

David Arkowitz — Chief Financial Officer

−9.5%1d on move date−7.0% vs SPY3d−10.1%5d−15.0%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MCRB calls or request research access.

More MCRB calls Browse calls Request research access